# A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)

> **NCT01732848** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 113 (actual)

## Conditions studied

- Healthy
- Hepatitis C

## Interventions

- **DRUG:** BMS-986094/INX-08189
- **DRUG:** Placebo matching BMS-986094/INX-08189

## Key facts

- **NCT ID:** NCT01732848
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 113 (ACTUAL)
- **Last updated:** 2014-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01732848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01732848, "A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01732848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*